Blueprint Medicines Corp (BPMC)
93.00
+2.27
(+2.50%)
USD |
NASDAQ |
Apr 26, 16:00
93.14
+0.14
(+0.16%)
After-Hours: 20:00
Blueprint Medicines Shares Outstanding: 61.23M for Feb. 13, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 13, 2024 | 61.23M |
December 31, 2023 | 61.15M |
October 23, 2023 | 60.79M |
September 30, 2023 | 60.74M |
July 28, 2023 | 60.66M |
June 30, 2023 | 60.64M |
April 28, 2023 | 60.47M |
April 24, 2023 | 60.45M |
March 31, 2023 | 60.42M |
February 14, 2023 | 59.98M |
December 31, 2022 | 59.96M |
October 28, 2022 | 59.83M |
September 30, 2022 | 59.81M |
July 29, 2022 | 59.72M |
June 30, 2022 | 59.69M |
April 29, 2022 | 59.57M |
April 25, 2022 | 59.57M |
March 31, 2022 | 59.56M |
February 15, 2022 | 59.20M |
December 31, 2021 | 59.14M |
October 25, 2021 | 58.84M |
September 30, 2021 | 58.81M |
July 26, 2021 | 58.57M |
June 30, 2021 | 58.55M |
April 26, 2021 | 58.34M |
Date | Value |
---|---|
April 09, 2021 | 58.29M |
March 31, 2021 | 58.28M |
February 15, 2021 | 57.96M |
December 31, 2020 | 57.79M |
October 26, 2020 | 55.73M |
September 30, 2020 | 55.51M |
July 24, 2020 | 55.27M |
June 30, 2020 | 54.28M |
April 30, 2020 | 54.19M |
April 24, 2020 | 54.19M |
March 31, 2020 | 54.17M |
February 10, 2020 | 54.03M |
January 27, 2020 | 53.98M |
December 31, 2019 | 49.27M |
October 31, 2019 | 49.20M |
September 30, 2019 | 49.18M |
July 26, 2019 | 49.12M |
June 30, 2019 | 49.06M |
May 06, 2019 | 48.85M |
April 22, 2019 | 48.85M |
April 02, 2019 | 48.76M |
March 31, 2019 | 44.17M |
February 15, 2019 | 44.10M |
December 31, 2018 | 44.04M |
October 26, 2018 | 43.95M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
48.85M
Minimum
May 06 2019
61.23M
Maximum
Feb 13 2024
57.14M
Average
58.69M
Median
Shares Outstanding Benchmarks
Alnylam Pharmaceuticals Inc | 125.95M |
Apellis Pharmaceuticals Inc | 120.58M |
Ionis Pharmaceuticals Inc | 145.75M |
Madrigal Pharmaceuticals Inc | 19.90M |
Sarepta Therapeutics Inc | 93.86M |